Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 18021 - 18040 out of 485350 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (RBX) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaANZPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (RBX) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SunPharmaANZPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
| Australia | (L01EA01) imatinib (adm: O) | Imatinib (Teva) 400 mg tablet, 30 | Tablet 400 mg (as mesilate), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaAustraliaPtyLtd |
Pages
